Open Access Open Access  Restricted Access Subscription or Fee Access
Antimalarial agents

Tetrahedral Hydroxyethylamine: A Privileged Scaffold in Development of Antimalarial Agents

Brijesh Rathi, Prem Prakash Sharma, R P Singh

Abstract


Hydroxyethylamine (HEA) based small molecules have extensively been evaluated for their antimalarial properties. HEA scaffold enabled generation of numerous chemical libraries with significant antimalarial activity. Besides, the tetrahedral HEA scaffold has been explored for the construction of inhibitors of malarial aspartic proteases, plasmepsin 1 and 2. This review deals with chemistry and evaluation of HEA based small molecules as antimalarial agents.

Keywords


Hydroxyethylamine; Tetrahedral; Malaria; Plasmepsin; Inhibitor

Full Text:

PDF

References


B.R. Stockwell. Exploring biology with small organic molecules. Nature 2004, 432, 846-54.

T.S. Haque, A.G. Skillman, C.E. Lee, H. Habashita, I.Y. Gluzman, T.J. Ewing, D.E. Goldberg, I.D. Kuntz, J.A. Ellman. Potent, low-molecular-weight non-peptide inhibitors of malarial aspartyl protease plasmepsin II. J. Med. Chem. 1999, 42, 1428-40.

D. Nöteberg, E. Hamelink, J. Hultén, M. Wahlgren, L. Vrang, B. Samuelsson, A. Hallberg. Design and Synthesis of Plasmepsin I and Plasmepsin II Inhibitors with Activity in Plasmodium f alciparum-Infected Cultured Human Erythrocytes. J. Med. Chem. 2003, 46, 734-46.

D. Nöteberg, W. Schaal, E. Hamelink, L. Vrang, M. Larhed. High-speed optimization of inhibitors of the malarial proteases plasmepsin I and II. J. Comb. Chem. 2003, 5, 456-64.

D. Muthas, D. Nöteberg, Y.A. Sabnis, E. Hamelink, L. Vrang, B. Samuelsson, A. Karlén, A. Hallberg. Synthesis, biological evaluation, and modeling studies of inhibitors aimed at the malarial proteases plasmepsins I and II. Bioorg. Med. Chem. 2005, 13, 5371-90.

C.-L. Ciana, R. Siegrist, H. Aissaoui, L. Marx, S. Racine, S. Meyer, C. Binkert, R. De Kanteret. al. Novel in vivo active anti-malarials based on a hydroxy-ethyl-amine scaffold. Bioorg. Med. Chem. Lett. 2013, 23, 658-62.

K. Jaudzems, K. Tars, G. Maurops, N. Ivdra, M. Otikovs, J. Leitans, I. Kanepe-Lapsa, I. Domracevaet. al. Plasmepsin Inhibitory Activity and Structure-Guided Optimization of a Potent Hydroxyethylamine-Based Antimalarial Hit. ACS Med. Chem. Lett. 2014, 5, 373-77.

M. Conceicao de Souza, T. Goncalves-Silva, M. Moreth, C. RB Gomes, C. Roland Kaiser, M.d.O.H. das Gracas, M. VN de Souza. Synthesis and In Vivo Antimalarial Evaluation of Novel Hydroxyethylamine Derivatives. Med. Chem. 2012, 8, 266-72.

W. Cunico, M.d.L.G. Ferreira, T.G. Ferreira, C. Penido, M.G. Henriques, L.G. Krettli, F.P. Varotti, A.U. Krettli. Synthesis and antimalarial activity of novel hydroxyethylamines, potential aspartyl protease inhibitors. Lett. Drug Des. Discov. 2008, 5, 178-81.

D. Gupta, R.S. Yedidi, S. Varghese, L.C. Kovari, P.M. Woster. Mechanism-based inhibitors of the aspartyl protease plasmepsin II as potential antimalarial agents. J. Med. Chem. 2010, 53, 4234-47.

V. Aureggi, V. Ehmke, J. Wieland, W.B. Schweizer, B. Bernet, D. Bur, S. Meyer, M. Rottmannet. al. Potent Inhibitors of Malarial Aspartic Proteases, the Plasmepsins, by Hydroformylation of Substituted 7‐Azanorbornenes. Chem. Eur. J. 2013, 19, 155-64.

P. Bhaumik, A. Gustchina, A. Wlodawer. Structural studies of vacuolar plasmepsins. BBA-Proteins Proteom. 2012, 1824, 207-23.

T. Miura, K. Hidaka, Y. Azai, K. Kashimoto, Y. Kawasaki, S.E. Chen, R.F. de Freitas, E. Freire, Y. Kiso. Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparum. Bioorg. Med. Chem. Lett. 2014, 24, 1698-701.

M. Chugh, V. Sundararaman, S. Kumar, V.S. Reddy, W.A. Siddiqui, K.D. Stuart, P. Malhotra. Protein complex directs hemoglobin-to-hemozoin formation in Plasmodium falciparum. Proc. Natl. Acad. Sci. 2013, 110, 5392-97.

J. Liu, E.S. Istvan, I.Y. Gluzman, J. Gross, D.E. Goldberg. Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems. Proc. Natl. Acad. Sci. 2006, 103, 8840-45.

A. Silva, A. Lee, S. Gulnik, P. Maier, J. Collins, T. Bhat, P. Collins, R. Cachauet. al. Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum. Proc. Natl. Acad. Sci. 1996, 93, 10034-39.

R. Wolfenden. Analog approaches to the structure of the transition state in enzyme reactions. Acc. Chem. Res. 1972, 5, 10-18.

G.E. Lienhard. Enzymatic catalysis and transition-state theory. Science 1973, 180, 149-54.

W. Cunico, C.R. Gomes, M. Moreth, D.P. Manhanini, I.H. Figueiredo, C. Penido, M.G. Henriques, F.P. Varotti, A.U. Krettli. Synthesis and antimalarial activity of hydroxyethylpiperazine derivatives. Eur. J. Med. Chem. 2009, 44, 1363-8.






ISSN 2347–9825